Add like
Add dislike
Add to saved papers

Obesity Paradox in Off-Pump Coronary Artery Bypass Surgery: Does It Benefit the Elderly?

BACKGROUND: The obesity paradox is a well-known phenomenon in cardiovascular disease; how it interferes with coronary artery revascularization remains controversial. The purpose of this study was to investigate the impact of obesity body mass index (BMI > 30; in kg/m2 ) on short- and long-term survival and major adverse cardiovascular event (MACE)-free survival in obese patients after off-pump coronary artery bypass operation.

METHODS: We retrospectively reviewed our prospective cohort of 1,400 consecutive and systematic patients who underwent off-pump coronary artery bypass operation between September 1996 and November 2007 and identified 448 (32%) with preoperative BMI greater than 30.

RESULTS: Patients with BMI greater than 30 patients were younger and had a higher prevalence of diabetes, dyslipidemia, hypertension, and percutaneous coronary interventions than patients with BMI less than 30. Thirty-day mortality and perioperative myocardial infarction were similar in both groups. No significant difference was observed for wound infections, sternal dehiscence, and reoperation for bleeding. Overall, long-term survival was comparable in the two groups, although obese patients older than 65 years had a better survival than the nonobese patients even after correction for risk factors (p = 0.04). MACE-free survival at 10 years was 65.3% ± 5.7% in obese and 76.3% ± 2.3% in nonobese patients (p = 0.007). Statistical significance was maintained (p = 0.008) after correction for risk factors. Among MACE, only new episodes of congestive heart failure were more prevalent in obese patients (p = 0.002).

CONCLUSIONS: In our series of off-pump coronary artery bypass operation, obesity was not an independent cause of short- and long-term mortality and was shown beneficial for older patients. However, obese patients had a lower MACE-free survival because of an increased incidence of rehospitalization for congestive heart failure.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app